To date, some studies have shown the significance of TAP1 or CXCL13 as reliable immune-related prognostic genes in ovarian cancer (Liu et al., 2020; Wu et al., 2020; Huo et al., 2021; Li et al., 2021). This evidence concerns the gene CXCL13 and ovarian cancer.